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Abstract
Introduction
The Patient Assessment of Chronic Illness Care (PACIC) 
survey is a patient-centered instrument for evaluating the 
quality  and  patient-centeredness  of  chronic  illness  care 
received according to the Chronic Care Model paradigm. 
This study validates the Spanish translation of the PACIC 
in an urban, Spanish-speaking population.
Methods
One hundred Spanish-speaking patients with diabetes 
completed  the  translated  PACIC  and  sociodemographic 
and  cultural  questionnaires.  Test-retest  reliability  was 
assessed  in  a  subset  of  20  patients  who  completed  the 
questionnaire  2  to  4  months  later.  Internal  consistency 
was evaluated with Cronbach α. PACIC score and subscale 
associations  with  sociodemographic  characteristics  were 
examined.
Results
Test-retest reliability for the overall translated PACIC 
scale was 0.77. Scores were not associated with patient 
sociodemographic characteristics, including age, country 
of birth, years living in the United States, or education 
level (P >.05).
Conclusion
The Spanish translation of the PACIC survey demon-
strated  high  reliability,  internal  consistency,  and  test-
retest  reliability.  Scores  showed  no  association  with 
sociodemographic or cultural characteristics. The Spanish 
version  can  reliably  be  used  to  assess  care  delivered 
according to the Chronic Care Model in a heterogeneous 
Spanish-speaking population.
Introduction
The  gap  between  evidence-based  medicine  and  pro-
active, patient-centered care has been well documented; 
the challenge for the near future is to bridge this divide 
(1-4).  A  paradigm  to  achieve  this  is  described  by  the 
Chronic Care Model (CCM) (5-7). This model provides a 
multidimensional  framework  for  improving  the  quality 
of chronic care through interventions targeting 6 critical 
domains: 1) organization of health care, 2) clinical infor-
mation  systems,  3)  delivery  system  design,  4)  decision 
support, 5) self-management support, and 6) community 
resources. When these CCM goals were applied as part of 
a Breakthrough collaborative (8), a diverse set of health 
care teams improved both process and outcome measures 
for 1 or more chronic illnesses on a panel-wide or popula-
tion  basis  (9,10).  When  applied  on  a  broader  scale,  the 
improvements in health care delivery to patients suffer-
ing from chronic illness may be further generalizable (1-
3,9,10). The urgent need for such change is underscored 
by the projected increase in people living with a chronic   
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.
  www.cdc.gov/pcd/issues/2008/oct/07_0180.htm • Centers for Disease Control and Prevention  1
Abraham Aragones, MD, MSCI, Eric W. Schaefer, MD, David Stevens, MD, Marc N. Gourevitch, MD, MPH, 
Russell E. Glasgow, PhD, Nirav R. Shah, MD, MPHVOLUME 5: NO. 4
OCTOBER 2008
condition in the United States — more than 134 million 
will be affected by 2020 (11) — and high rates of subopti-
mal chronic care demonstrated in several studies (11,12).
Evaluating the effect of any complex intervention imple-
mented  in  a  health  care  delivery  system  is  difficult. 
Several means are being developed to assess the effect of 
CCM implementation on systems of care. The Assessment 
of  Chronic  Illness  Care  (ACIC)  (13)  and  the  Patient 
Assessment of Chronic Illness Care (PACIC) (14) survey 
instruments have been developed to assess CCM imple-
mentation at the level of the provider and patient, respec-
tively. The ACIC instrument was developed to measure 
the extent to which health care teams employ CCM ele-
ments with their patients (13); it is completed by care pro-
viders. In a pilot trial involving health care teams treating 
various  chronic  illnesses,  ACIC  scores  were  positively 
correlated with quality-improvement efforts launched as a 
component of CCM implementation (13).
Complementing  the  ACIC  is  the  PACIC,  a  20-item 
patient  survey  that  assesses  a  patient’s  receipt  of  care 
congruent with key aspects of the CCM for their chronic 
illness during the previous 6 months (14). This instru-
ment  assesses  key  elements  of  the  CCM:  collaborative 
self-management  support  and  planned,  proactive,  and 
population-based care and follow-up. The PACIC provides 
a patient-centered assessment of the quality of chronic 
illness care, helping health care teams better understand 
the level of integration of CCM care in their practices. 
This tool is the only one available in the literature that 
measures  patients’  assessment  of  chronic  disease  care 
received under the CCM. The PACIC avoids the common 
pitfall of clinician overreporting of the elements of care 
delivered. As with many patient assessments, the PACIC 
empowers patients to be evaluators in their health care 
(15). More importantly, the PACIC may serve as a bench-
mark of care for health care teams. Changes in health 
care delivery may be assessed over time by readminister-
ing this instrument (14).
The  English  version  of  the  PACIC  questionnaire  was 
developed  and  validated  by  Glasgow  et  al  (14).  It  was 
developed and tested among 283 patients receiving care 
for 1 or more chronic conditions under the CCM in a large 
managed  care  organization  in  Washington  and  Idaho. 
The PACIC consists of 20 items that were chosen from 46 
items designed by national experts on chronic illness care 
and the CCM. This questionnaire (Appendix I) is divided 
into 5 subscales to reflect the key components of the CCM: 
patient activation (3 questions), delivery system design/
decision  support  (3  questions),  goal  setting/tailoring  (5 
questions), problem-solving/contextual (4 questions), and 
follow-up/coordination (5 questions). Each item has a score 
from 1 (never) to 5 (always). Patients self-report how often 
they received specific types of medical care during the past 
6 months. The questionnaire can be self-administered or 
staff-administered. The total score for the questionnaire 
and for each subscale is then tabulated. The concurrent 
validity of the English version of the PACIC instrument 
was assessed by correlating its scores with results from 
other instruments that measure delivery of primary care 
(14). The authors found good reliability and good face, con-
struct, and concurrent validity.
The PACIC was initially tested and validated in a popu-
lation  of  mostly  white,  English-speaking  patients  with 
various chronic illnesses (14), and more recently with a 
sample of English-speaking patients with diabetes (16). 
With  the  well-documented  challenges  of  health  dispari-
ties in the United States (17) and the rapid growth of the 
Hispanic/Latino population in the United States (18), there 
is now a need to assess chronic care services received by 
this group. The aim of our study was to test and validate 
the psychometric properties of the Spanish translation of 
the PACIC and to better understand the effect of the CCM 
in this population.
Methods
PACIC questionnaire translation
Using accepted guidelines for translation–back transla-
tion (19-21), the English version of the PACIC question-
naire  was  translated  into  Spanish  by  2  native  Spanish 
speakers fluent in English and medical terminology. Two 
different translators then independently back translated 
the  Spanish  version  into  English,  with  any  differences 
resolved by consensus. The back-translated English ver-
sion was then compared with the original English version 
to ensure that no loss of meaning or context occurred dur-
ing the translation process. The translated questionnaire 
is in Appendix II.
Population
For this cross-sectional validation study, we recruited 
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were receiving care at an adult ambulatory care clinic of a 
large municipal hospital in New York City. This clinic was 
selected because the physicians and staff have participated 
in a Breakthrough Series Collaborative led by Ed Wagner 
of the MacColl Institute, a leading proponent of the CCM. 
Components of the CCM have been integrated into aspects 
of care in this clinic since 2004, and biannual feedback is 
discussed at a citywide CCM collaborative.
A  trained  bilingual  research  assistant  approached  all 
patients  (previously  identified  as  having  type  2  diabe-
tes)  in  the  waiting  room  of  the  clinic  before  their  visit 
with  their  provider.  Those  who  acknowledged  speaking 
Spanish, met all the inclusion criteria, and consented to 
participate in the study were administered the translated 
Spanish PACIC questionnaire and were asked additional 
demographic and cultural questions. Clinical information 
was obtained by an electronic chart review. All patients 
recruited  in  the  study  self-reported  Spanish  as  their 
primary language, were aged 18 years or older, reported 
using the clinic as their primary source of medical care, 
and had at least 1 visit in the 6 months before the enroll-
ment visit. To reduce variability in reporting health care 
received for chronic illnesses, we selected patients who had 
a chronic medical condition in common: type 2 diabetes. Of 
the 120 patients who were approached and met criteria to 
participate in the study, 20 refused to participate, most 
often because of time constraints (80% of refusals).
Analyses
We  computed  means,  standard  deviations,  confidence 
intervals, and distributions of scores of the overall PACIC 
and  its  5  subscales.  All  calculations  were  conducted  by 
using SPSS 14.0 for Windows (SPSS Inc, Chicago, Illinois). 
Data collected on demographic factors included age, sex, 
marital status, educational level, insurance status, country 
of birth, the number of years living in the United States, 
and number of chronic conditions the patient had. From 2 
to 4 months after the initial survey, 20 patients (20% of the 
overall sample) were randomly selected by using SPSS’s 
simple random sampling method. These patients completed 
a telephone interview with the translated Spanish PACIC. 
We  evaluated  reliability  and  internal  consistency  of  the 
PACIC and its subscales using Cronbach α (22,23). We cor-
related patient demographics and PACIC scores by using 
Spearman rank order correlation because of the nonnormal 
distribution of the PACIC scores. We performed factor load-
ing analysis to confirm the correlation of the independent 
items within each subscale by using the varimax rotation 
(22,24),  a  criterion  that  maximizes  the  variance  of  the 
squared elements in the factor matrix. We selected this 
method because we had no reason to suspect a principal 
factor and because interpretation would be easier.
This study was approved by the New York University 
School of Medicine institutional review board.
Results
Respondent characteristics
The 100 Spanish-speaking patients with diabetes com-
pleted  the  translated  PACIC  between  April  2006  and 
February 2007. Seventy-nine percent of participants were 
women, 46% had an education level below sixth grade, 
and 10% were uninsured. Most patients (69%) were born 
in  Spanish-speaking  Caribbean  countries  (Table  1).  No 
demographic characteristics, including number of years in 
the United States, were significantly associated with over-
all PACIC scores or subscales or had correlations higher 
than 0.18 (Table 2). We found no significant differences in 
patient demographic characteristics (age, sex, and number 
of years since moving to the United States) between those 
who consented to participate in the study and those who 
did not.
PACIC reliability
The average overall PACIC score was 3.17 (SD, 0.82). 
Mean subscale scores ranged from 2.50 to 3.95 (Table 3). 
Neither ceiling nor floor effects were observed (ie, scores 
were not clustered near the top or bottom range of the 
scale), suggesting good discrimination potential. Internal 
consistency of the overall PACIC (Cronbach α) was 0.87 
and test-retest reliability (Cronbach α) was 0.77 (Table 3), 
suggesting excellent internal consistency and test-retest 
reliability. For internal consistency, all subscales had a 
Cronbach  α  greater  than  0.6  for  the  complete  sample, 
which is acceptable for brief scales (23,25). One subscale, 
delivery system design/decision support, had Cronbach α 
<0.6 in the test-retest component.
Confirmatory factor analysis
The results of the factor analysis for each of the PACIC 
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subscales  are  listed  in  Table  4.  Most  of  the  items  cor-
related highly on the proposed scales. Of the 20 items,   
13 had factor loading (α) greater than 0.7 and only 1 item 
had factor loading less than 0.6 (question 17, α = 0.48).
Discussion
The  Spanish  translation  of  the  PACIC  questionnaire 
demonstrated  high  reliability,  internal  consistency,  and 
test-retest reliability, extending the applicability of this 
instrument  to  Spanish-speaking  patients.  Given  the 
increase in the proportion of Spanish-speaking patients 
in  the  United  States  (18)  and  the  increased  use  of  the 
CCM to guide system change in hospital and community 
settings (26,27), there is a pressing need for practical, vali-
dated tools to evaluate the CCM among Spanish-speaking 
persons. We believe this translated PACIC questionnaire 
begins to fill that void.
PACIC scores should not be related to patients’ demo-
graphic characteristics, as noted by the developers of the 
original English version of this scale (16). Indeed, we found 
that  PACIC  scores  in  the  Spanish-speaking  population 
studied were not correlated with the number of chronic 
medical  conditions  or  with  sociodemographic  character-
istics such as age, number of years in the United States, 
level of education, or country of origin. This suggests that 
overall,  the  translation  was  successful  despite  possible 
variations in other unmeasured factors such as cultural 
aspects and health literacy.
The  factor  analysis  demonstrated  that  almost  every 
question fit well into its particular subscale. The exception 
was question 17, but the difference did not reach statisti-
cal significance. This question asks whether patients were 
encouraged to attend community programs to aid in their 
chronic  illness  care.  Patients  possibly  understood  the 
medical clinic itself to be their “community” health care 
resource, and they therefore did not pursue other commu-
nity resources.
The  population  studied  was  limited  to  patients  with 
diabetes  to  reduce  the  variability  in  care  received,  and 
our study provides a direct cross-validation of the Spanish 
version  with  the  English-speaking  diabetes  validation 
(16). Although patients with other chronic medical condi-
tions may view their medical care differently from those 
with diabetes, the original English PACIC was tested in 
populations with various chronic conditions yet displayed 
no differences in its psychometric properties across these 
conditions (14).
This study recruited patients from only 1 health care 
setting.  Conceivably,  the  6  domains  of  the  CCM  might 
translate differently depending on the environment. For 
example, patients might view their care differently in a 
specialty clinic relative to a primary care setting. Though 
this may affect the generalizability of the results of our 
assessment of the Spanish translation of the PACIC ques-
tionnaire,  its  essential  reliability  and  consistency,  dem-
onstrated  herein,  should  not  be  affected.  We  encourage 
other researchers to replicate this study among Spanish- 
speaking patients receiving care under the CCM for differ-
ent chronic conditions.
Glasgow et al found that the PACIC was useful in assess-
ing care delivered to patients with diabetes and encour-
aged its integration into quality improvement initiatives 
(16). Our results confirm that the Spanish translation of 
the PACIC questionnaire can be used in a mixed Hispanic 
population and still retain excellent psychometric proper-
ties despite the potential for cultural or ethnic variations. 
Once additional validation studies are conducted on dif-
ferent, independent samples, we believe this tool can be 
used to assess the implementation of the CCM in various 
clinical settings with Hispanic populations and to aid in 
both formal evaluation and quality improvement projects 
to  enhance  the  delivery  of  patient-centered  health  care 
among Spanish-speaking populations.
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Characteristic Value
Age, y
Mean (SD) .7 (10.7)
Range 7-80
Sex, %
Male 21
Female 79
Marital status, %
Married 
Widowed 28
Single 1
Divorced 11
Other 12
Education level, %
≤6th grade 4
7th-12th grade 4
More than high school 11
Insurance status, %
Insured 90
Uninsured 10
Characteristic Value
Country of birth, %
Puerto Rico 
Dominican Republic 
Mexico 8
United States 5
Other 18
No. of years living in United States
Mean (SD) 4.9 (1.4)
Range 1-0
No. of chronic conditions (excluding diabetes)
Mean (SD) 4.2 (1.7)
Range 0-9
High blood pressure, % 7
Pain, % 7
Arthritis, % 0
Depression, % 2
Asthma, % 21
Tables
Table 1. Sociodemographic Characteristics of Spanish-Speaking Patients With Diabetes, Spanish Translation of the Patient 
Assessment of Chronic Illness Care Survey (N = 100), New York City, 2006–2007Table 2. Correlationa of Demographic Characteristics of Spanish-Speaking Patients With Diabetes and Their Scores From a 
Spanish Translation of the Patient Assessment of Chronic Illness Care (PACIC) Survey (N = 100), New York City, 2006–2007
Scale Age % Male Education Level
Insurance 
Status
No. of Years 
Living in United 
States
No. of Chronic 
Conditions 
(Excluding 
Diabetes)
Overall PACIC 0.02 −0.01 0.02 0.14 0.01 0.0
Patient activation −0.17 0.0 0.14 −0.09 0.0 0.02
Delivery system design/decision support 0.09 −0.01 −0.004 0.11 0.002 0.04
Goal setting/tailoring 0.09 0.05 −0.08 0.18 0.09 0.08
Problem solving/contextual 0.04 −0.11 −0.05 0.17 −0.01 −0.05
Follow-up/coordination 0.02  −0.02 0.14 0.12 −0.04 0.05
 
a Spearman rank order correlation. No values are statistically significant (P >.05 for all).
Table 3. Scores and Reliability of a Spanish Translation of the Patient Assessment of Chronic Illness Care (PACIC) Survey 
Among Spanish-Speaking Patients With Diabetes (N = 100), New York City, 2006–2007
Scale Mean (SD)
Cronbach α
Internal Consistency 
(N = 100)
Test-Retest 
(n = 20)
Overall PACIC .17 (0.82) 0.87 0.77
Patient activation 2.9 (1.25) 0.1 0.1
Delivery system design/decision support .95 (0.98) 0.0 0.50
Goal setting/tailoring .09 (1.08) 0.7 0.9
Problem solving/contextual .75 (1.10) 0.70 0.2
Follow-up/coordination 2.50 (0.90) 0.0 0.74
Table 4. Instrument Properties and Confirmatory Analysis of a Spanish Translation of the Patient Assessment of Chronic 
Illness Care Survey Scale Among Spanish-Speaking Patients With Diabetes (N = 100), New York City, 2006–2007
Scale/Questiona
Eigenvalues
Factor Loading (α) Total % of Variance Cumulative %
Patient activation
1 1.70 5.7 5.7 0.77
2 0.81 27.07 8.79 0.84
 0.49 1.21 100.00 0.
Delivery system design/decision support
4 1.71 57.11 57.11 0.74
5 0.7 25.44 82.55 0.9
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Scale/Questiona
Eigenvalues
Factor Loading (α) Total % of Variance Cumulative %
Delivery system design/decision support (continued)
 0.52 17.45 100.00 0.82
Goal setting/tailoring
7 2.44 48.87 48.87 0.78
8 0.77 15.49 4.5 0.7
9 0.7 14. 78.98 0.5
10 0.5 1.02 92.00 0.1
11 0.40 8.00 100.00 0.7
Problem solving/contextual
12 2.1 5.91 5.91 0.72
1 0.95 2.5 77.57 0.80
14 0.5 1.1 90.87 0.8
15 0.7 9.1 100.00 0.7
Follow-up/coordination
1 1.97 9.4 9.4 0.72
17 1.0 21.11 0.45 0.48
18 0.9 18. 79.11 0.8
19 0.0 11.97 91.07 0.81
20 0.45 8.9 100.00 0.80
 
a The questions are listed in Appendix I (English) and Appendix II (Spanish).
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Table 4. (continued) Instrument Properties and Confirmatory Analysis of a Spanish Translation of the Patient Assessment of 
Chronic Illness Care Survey Scale Among Spanish-Speaking Patients With Diabetes (N = 100), New York City, 2006–2007Appendices
Appendix I. English Version of the Patient Assessment of Chronic Illness Care Questionnaire
Source: Reference 14.
Assessment of Care for Chronic Conditions
Staying healthy can be difficult when you have a chronic condition. We would like to learn about the type of help with your condition you get from your 
health care team. This might include your regular doctor, his or her nurse, or physician’s assistant who treats your illness. Your answers will be kept confi-
dential and will not be shared with your physician or clinic.
Over the past  months, when I received care for my chronic conditions, I was:
 
 
None of 
the Time
A Little of 
the Time
Some of 
the Time
Most of 
the Time
Always
1. Asked for my ideas when we made a treatment plan.  1  2    4  5
2. Given choices about treatment to think about.  1  2    4  5
. Asked to talk about any problems with my medicines or their effects.  1  2    4  5
4. Given a written list of things I should do to improve my health.  1  2    4  5
5. Satisfied that my care was well organized.  1  2    4  5
. Shown how what I did to take care of myself influenced my condition.  1  2    4  5
7. Asked to talk about my goals in caring for my condition.  1  2    4  5
8. Helped to set specific goals to improve my eating or exercise.  1  2    4  5
9. Given a copy of my treatment plan.  1  2    4  5
10. Encouraged to go to a specific group or class to help me cope with my chronic  
condition.
 1  2    4  5
11. Asked questions, either directly or on a survey, about my health habits.  1  2    4  5
12. Sure that my doctor or nurse thought about my values, beliefs, and traditions when 
they recommended treatments to me.
 1  2    4  5
1. Helped to make a treatment plan that I could carry out in my daily life.  1  2    4  5
14. Helped to plan ahead so I could take care of my condition even in hard times.  1  2    4  5
15. Asked how my chronic condition affects my life.  1  2    4  5
1. Contacted after a visit to see how things were going.  1  2    4  5
17. Encouraged to attend programs in the community that could help me.  1  2    4  5
18. Referred to a dietitian, health educator, or counselor.  1  2    4  5
19. Told how my visits with other types of doctors, like an eye doctor or surgeon, helped 
my treatment.
 1  2    4  5
20. Asked how my visits with other doctors were going.  1  2    4  5
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Appendix II. Spanish Version of the Patient Assessment of Chronic Illness Care Questionnaire
Source for original English version: Reference 14.
Evaluación del Cuidado de Enfermedades/Condiciones Crónicas
Mantenerse saludable puede ser difícil cuando tiene una enfermedad crónica. Quisiéramos saber el tipo de ayuda que usted recibe de su equipo de cui-
dado de la salud. Esto podría incluir aquellos que tratan su enfermedad como su doctor regular, su enfermero/a o asistente medico. Sus respuestas se 
mantendrán confidenciales y no serán compartidas con su medico o la clínica.
En los últimos  meses, cuando recibí cuidado medico por mi enfermedad crónica:
 
  Nunca
Pocas 
Veces
Algunas 
Veces
La Mayoría 
del Tiempo Siempre
1. Me preguntaron lo que yo pensaba cuando tomamos la decisión del plan para mi 
tratamiento.
 1  2    4  5
2. Me dieron diferentes alternativas de tratamientos para que lo pensara.  1  2    4  5
. Me preguntaron si tengo algún problema con mis medicamentos o sus efectos.  1  2    4  5
4. Me dieron una lista escrita de cosas que debo hacer para mejorar mi salud.  1  2    4  5
5. Estaba satisfecho que mi cuidado medico estaba bien organizado.  1  2    4  5
. Me mostraron como lo que yo he echo para cuidarme influencio mi enfermedad/
condición.
 1  2    4  5
7. Me pidieron que hable sobre mis metas en cuanto al cuidado de mi enfermedad/
condición.
 1  2    4  5
8. Me ayudaron a establecer metas específicas para mejorar mi alimentación y ejercicios.  1  2    4  5
9. Me dieron una copia del plan para mi tratamiento.  1  2    4  5
10. Me animaron a que vaya a un grupo específico o a una clase para que me ayude a 
hacer frente a mi enfermedad/condición crónica.
 1  2    4  5
11. Me hicieron preguntas, directamente o a través de un cuestionario, acerca de mis 
hábitos relacionados a la salud.
 1  2    4  5
12. Estaba seguro que mi medico o enfermero/a pensó en mis valores, creencias y tradi-
ciones cuando me recomendaron el tratamiento.
 1  2    4  5
1. Me ayudaron a crear un plan para mi tratamiento que yo pudiera realizar en mi vida 
cotidiana.
 1  2    4  5
14. Me ayudaron a planificar con tiempo para poder cuidar de mi enfermedad/condición 
aun en tiempos difíciles.
 1  2    4  5
15. Me preguntaron como mi condición/enfermedad crónica afecta mi vida.  1  2    4  5
1. Me contactaron después de mi visita para ver como iban las cosas.  1  2    4  5
17. Me animaron a que vaya a programas en mi comunidad que me podrían ayudar.  1  2    4  5
18. Me enviaron a un dietista/nutricionista, educador de la salud o a un consejero.  1  2    4  5
19. Me dijeron como las visitas a otros médicos, como el oftalmólogo o el cirujano ayud-
aron con mi tratamiento.
 1  2    4  5
20. Me preguntaron como estaban yendo las visitas a los otros médicos.  1  2    4  5
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